CUMBERLAND PHARMACEUTICALS INC (CPIX) › Capital ExpendituresCUMBERLAND PHARMACEUTICALS INC (CPIX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $601.8K2010: $577.2K2011: $257.5K2012: $464.9K2013: $97.4K2014: $163.3K2015: $143.0K2016: $130.9K2017: $276.0K2018: $455.6K2019: $246.2K2020: $140.8K2021: $103.5K2022: $102.1K2023: $281.3K2024: $66.5K2025: $97.9K$97.9K2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$97.9K+47.3%2024$66.5K-76.4%2023$281.3K+175.4%2022$102.1K-1.3%2021$103.5K-26.5%2020$140.8K-42.8%2019$246.2K-46.0%2018$455.6K+65.1%2017$276.0K+110.9%2016$130.9K-8.5%2015$143.0K-12.4%2014$163.3K+67.6%2013$97.4K-79.0%2012$464.9K+80.5%2011$257.5K-55.4%2010$577.2K-4.1%2009$601.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share